echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Br J Cancer: Metformin can improve the prognosis of patients with gastric adenocarcinoma

    Br J Cancer: Metformin can improve the prognosis of patients with gastric adenocarcinoma

    • Last Update: 2021-05-31
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    As a common disease, gastric cancer has a poor overall prognosis.


    As a common disease, gastric cancer has a poor overall prognosis.


    Gastric adenocarcinoma is the main histological type of gastric cancer (>95%).


    The treatment strategy of gastric adenocarcinoma generally adopts a multidisciplinary approach, in which surgical resection (gastrectomy) is the main treatment method, while patients with unresectable or metastatic disease usually adopt chemotherapy and targeted therapies.



    Recent studies have shown that metformin, as a first-line drug for diabetes , can improve the prognosis of patients with colon cancer and prostate cancer.


    Metformin diabetic colon cancer



    Kaplan-Meier survival curve of metformin in the treatment of gastric adenocarcinoma

    Kaplan-Meier survival curve of metformin in the treatment of gastric adenocarcinoma

    The researchers assessed the relationship between the use of metformin before diagnosis of gastric adenocarcinoma and the disease-specific mortality and all-cause mortality through multivariate Cox risk regression analysis.




    Comparison of cumulative mortality curves between metformin users and non-users

    Comparison of cumulative mortality curves between metformin users and non-users

    All in all, the results of the study reveal that metformin can improve the survival rate of gastric adenocarcinoma patients with diabetes.


    The results of the study revealed that metformin can improve the survival rate of gastric adenocarcinoma patients with diabetes.



    org/10.




    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.